 A series of pyridoxine resveratrol hybrids were designed and synthesized as monoamine oxidase B inhibitors for the treatment of Parkinsons disease . Most of them exhibited potent inhibitory activities on MAO B with high selectivity . Specifically compounds

@highlight Novel pyridoxine resveratrol hybrids were synthesized.
@highlight Most compounds showed selective MAO B inhibitory and antioxidant activities.
@highlight Compound
@highlight and
@highlight exhibited tight and reversible connection with MAO B.
@highlight and
@highlight showed good neuroprotective effects.
@highlight These compounds also showed high blood brain barrier permeability.
